Cargando…
Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma
Glioma is the most common and aggressive type of primary brain malignant tumor with limited treatment approaches. Methyltransferase-like 7B (METTL7B) is associated with the pathogenesis of several diseases but is rarely studied in glioma. In this study, 1,493 glioma samples (data from our cohort, TC...
Autores principales: | Chen, Xiaochuan, Li, Chao, Li, Ying, Wu, Shihong, Liu, Wei, Lin, Ting, Li, Miaomiao, Weng, Youliang, Lin, Wanzun, Qiu, Sufang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484875/ https://www.ncbi.nlm.nih.gov/pubmed/34604305 http://dx.doi.org/10.3389/fmolb.2021.727481 |
Ejemplares similares
-
Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
por: Lin, Wanzun, et al.
Publicado: (2020) -
Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
por: Wan, Lingfei, et al.
Publicado: (2023) -
Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021) -
Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy
por: Yang, Dashuai, et al.
Publicado: (2023) -
Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)